A suppository Chinese medicine (Xilei-san) for refractory ulcerative proctitis: A pilot clinical trial [13]

Digestion

Volumn 75, Issue 2-3, 2007, Pages 146-147

  Fukunaga, Ken ^a   Hida, Nobuyuki ^a   Ohnishi, Kunio ^a   Ohda, Yoshio ^a   Yoshida, Koji ^a   Kusaka, Takeshi ^a   Jinno, Yoshio ^a   Nagase, Kazuko ^a   Nakamura, Shiro ^a   Kadobayashi, Muneo ^a   Miwa, Hiroto ^a   Matsumoto, Takayuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; HYDROCORTISONE; MESALAZINE; SALAZOSULFAPYRIDINE; SUPPOSITORY BASE; UNCLASSIFIED DRUG; XILEI SAN;

ADULT; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PROCTITIS; STATISTICAL ANALYSIS; SUPPOSITORY; TREATMENT OUTCOME; ULCERATIVE COLITIS; ULCERATIVE PROCTITIS;

ADULT; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PILOT PROJECTS; PROCTITIS; PROSPECTIVE STUDIES; SUPPOSITORIES; TREATMENT OUTCOME;

EID: 34548316017     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106755     Document Type: Letter

References (8)

1. d'Albasio G, Paoluzi P, Camieri M, et al: Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. The Italian IBD Study Group. Am J Gastroenterol 1998;93:799-803.
2. Rachmilewitz D: Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989;298:82-86.
3. Irvine EJ: A quality-of-life index for inflammatory bowel disease. Can J Gastroenterol 1993;7:155-159.
4. Williams CN: Role of rectal formulations: suppositories. Scand J Gastroenterol Suppul 1990;172:60-62.
5. Campieri M, Gionchetti P, Belluzzi A, et al: 5-Aminosalicylic acid suppositories in the management of ulcerative colitis. Dis Colon Rectum 1989;32:398-399.
6. Farup PG, Hovde O, Halvorsen FA, Raknerud N, Brodin U: Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis: a comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol 1995;30:164-170.
7. Amano K, Amano K, Kume K, Nakamura K, Chin S: Xileisan as the new drug for the treatment of ulcerative colitis. Annual Report of the Research Committee of Inflammatory Bowel Disease (in Japanese). Tokyo, Ministry of Health, Labor and Welfare of Japan, 2000, pp 137-138.
8. Ohu B, Higuchi K, Fukuda T, et al: Anti-ulceration efficiency of Xilei San (Chinese medicine) (in Japanese). Prog Med 1989;9:2847-2852.